Christos Dimopoulos - 21 Nov 2025 Form 4 Insider Report for Bunge Global SA (BG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Nov 2025, 19:59:46 UTC
Prior SEC filing
04 Sep 2025
Next SEC filing
03 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Drew Yaeger, Attorney-in-Fact

Key filing fact

Christos Dimopoulos filed Form 4 for Bunge Global SA (BG) on 25 Nov 2025.

Key facts

  • This page summarizes Christos Dimopoulos's Form 4 filing for Bunge Global SA (BG).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 25 Nov 2025, 19:59.

Change

  • Previous filing in this sequence was filed on 04 Sep 2025.
  • Current net transaction value: -$2,122,273.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001758115 Primary reporting owner

Dimopoulos Christos

Relationship
Executive VP, Global Markets
Address
C/O BUNGE GLOBAL SA, 1391 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD
Signature
/s/ Drew Yaeger, Attorney-in-Fact
Signature date
25 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BG transaction

Common Stock

Options Exercise

Transaction value
$265,371
Shares
+5,300
Change %
+4.3%
Price
$50.07
Shares after
129,837
Date
21 Nov 2025
Ownership
Direct
BG transaction

Common Stock

Sale

Transaction value
$500,226
Shares
-5,300
Change %
-4.1%
Price
$94.38
Shares after
124,537
Date
21 Nov 2025
Ownership
Direct
Footnotes
F1
BG transaction

Common Stock

Sale

Transaction value
$1,887,418
Shares
-20,000
Change %
-16%
Price
$94.37
Shares after
104,537
Date
21 Nov 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BG transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value
$0
Shares
-5,300
Change %
-100%
Price
$0.000000
Shares after
0
Date
21 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,300
Exercise price
$50.07
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $94.30 to $94.48. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $94.28 to $94.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

Footnote F3

This option became exercisable in three equal annual installments beginning on March 1, 2017.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .